视觉图像简单识别测试,一种语言最小化的识别测试:阿尔茨海默病的心理测量和临床评估
Shun Akaike1, Akihiko Ogata2, Yoshitsugu Nakagawa3
1Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
Journal of Alzheimer's disease : JAD
|December 12, 2025
概括
视觉图像简单识别测试 (VISRET) 可以有效地检测阿尔茨海默病 (AD) 的记忆丧失,并具有高准确性. 这种简短的,语言最小化的工具显示出临床使用的希望,即使在患有失语症的患者中也是如此.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 老年学是指老年学的学科.
背景情况:
- 在阿尔茨海默氏症 (AD) 中的情节性记忆评估传统上依赖于口头或基于绘图的测试.
- 这些方法可能受到语言障碍的影响,使准确的诊断变得复杂.
研究的目的:
- 开发和验证视觉图像简单识别测试 (VISRET) 作为评估AD记忆的新工具.
- 评估其心理测量特性,包括可靠性,有效性和诊断歧视.
主要方法:
- 这项研究包括149名参与者:62名健康参与者 (HP),53名阿尔茨海默氏症患者和34名阿法西亚患者 (AP).
- 心理测量评估涉及评估内部一致性 (斯皮尔曼-布朗),已知组有效性以及贝叶斯逻辑/线性模型的歧视和得分导出.
- 对衍生出来的记忆得分和切断值进行了交叉验证.
主要成果:
- 维斯雷特在AD (SB=0.87) 中表现出良好的内部一致性,在AD和HP (AUC=0.99) 之间表现出良好的区别,对年龄和失语症具有强大影响.
- 该测试与已建立的情节性记忆测试 (ρ=0.60) 显示出良好的融合有效性,以及与非记忆领域的最小相关性.
- 对VISRET记忆评分的交叉验证截止值在95%的HPD值实现了高灵敏度 (0.87) 和特异性 (0.95).
结论:
- VISRET是一种简短的,语言最小化的识别测试,有效地帮助检测与AD相关的记忆障碍.
- 该测试对失言症的影响最小,为传统记忆评估提供了有价值的替代方案.
- 衍生出来的记忆评分和切断值显示稳定的表现,表明AD诊断的潜在临床实用性.
相关概念视频
Visual Agnosia
892
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
892
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


